The Certified Insurance Service Representative (CISR) Director General Dr. Shekhar C. Mande while talking about drugs that can be useful against COVID-19 informed that the Drug Controller General of India has given approval for clinical trials of Favipiravir which is used in influenza in Japan, China etc.
Recommended Video
Top News
Latest News
